LABD Direxion Daily S&P Biotech Bear 3X Shares

*Unless otherwise stated, data provided by FactSet.

LABD Fund Description

LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.

LABD Factset Analytics Insight

LABD is a daily leveraged inverse (-3x) bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment. It gets its leverage exposure through a through a portfolio of swaps that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path-dependent and is likely to be different from -3x the return of the index for the same period. This makes LABD suitable primarily for short-term traders. Over time, compounding effects can lead to profound differences in expected returns relative to the index.

PERFORMANCE [as of 09/29/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
LABD 10.07% -35.99% -5.28% 13.87% -63.43% -51.39% --
LABD (NAV) 10.67% -35.53% -5.03% 14.16% -63.38% -51.35% --
S&P Biotechnology Select Industry Index -6.16% 5.40% -29.50% -37.10% 1.19% -1.70% 9.90%
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

LABD Summary Data

Direxion
05/28/15
Open-Ended Fund
0.96%
$163.43M
0.06%
N/A

LABD Portfolio Data

5.48%
N/A

LABD Index Data

Equal
Market Cap
N/A

LABD Fund Structure

Yes
No
-- / --
N/A
N/A
Low
-3
Daily

LABD Tax Exposures

20.00% / 39.60%
--
No

LABD Factset Analytics Block Liquidity

As of 09/30/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of LABD. LABD is rated a 5 out of 5.

LABD Tradability

12,784,758
$263.79M
12,181,041
$261.02M
0.06%
$0.01
-0.08%
4.21% / -0.68%
None
100.00%
50,000
243.62
0.00%
--
23,087
$24.49
5